Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
NVO
TSVT
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EBS
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
MRK
Florida Cannabis Ballot: NFL's Ricky Williams Backs Legalization, New Ad 'Hypocrisy Of Alcohol Vs. Marijuana'
September 24, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Creative Biolabs: Lock and Load with Next-Gen mRNA Tech
September 24, 2024
Via
Get News
Topics
Death
Exposures
COVID-19
Death
Product Safety
Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership
September 24, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
AMRX
LLY
NTRB
NTRBW
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU announced
September 24, 2024
Via
PR Leap
Exposures
Product Safety
Graphic Cabin™ by Hatfield Creative: Your Local Partner for Custom Beverage Labels, Wall Decals, and Trade Show Displays
September 23, 2024
Via
Syndication Cloud
Exposures
Product Safety
Cybersecurity for Medical Devices: 4 Ways to Remain Compliant
September 23, 2024
Via
Syndication Cloud
Exposures
Product Safety
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
September 23, 2024
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Tickers
GILD
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
September 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BHVN
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations
September 23, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
TNXP
New Study Warns of High Dose "ADHD" Drugs Inducing Psychosis
September 23, 2024
Via
PRLog
Exposures
Product Safety
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
September 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SNY
BOQU Instrument Elevates Professional Standards in Water Quality Sensors and Analyzers
September 20, 2024
Via
AB Newswire
Topics
Intellectual Property
Supply Chain
Exposures
Intellectual Property
Product Safety
Supply Chain
Approved for Domestic Market, OT-1001 Ushers in a New Era for Pediatric Allergic Conjunctivitis Treatment
September 20, 2024
Via
AB Newswire
Exposures
Product Safety
Burning Daily Announces Enhanced Brand Selection Standards to Ensure Premium Products for Customers.
September 20, 2024
Via
GetFeatured
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death
September 20, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ICUI
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ABBV
BMY
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
JNJ
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
JNJ
ZVRA
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
September 20, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ELAN
ZTS
GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid
September 20, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
GM
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects
September 19, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ICUI
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines
September 19, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
TNXP
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
September 19, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VNDA
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
September 18, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Product Safety
Flipping the Script on LBPs: Creative Biolabs Delivers Game-Changing Analytical Services
September 18, 2024
Via
Get News
Exposures
Product Safety
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
September 18, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZBH
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.